Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Sunday 05.04.2020 at 10:00 AM CEST
Settings

Settings

1. WO1996004261 - BENZOXAZOLES AND PRYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF THE TYPE II DIABETES

Publication Number WO/1996/004261
Publication Date 15.02.1996
International Application No. PCT/GB1995/001323
International Filing Date 07.06.1995
Chapter 2 Demand Filed 05.02.1996
IPC
C07D 213/74 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
213Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02having three double bonds between ring members or between ring members and non-ring members
04having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
60with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
72Nitrogen atoms
74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
C07D 263/58 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
263Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
52condensed with carbocyclic rings or ring systems
54Benzoxazoles; Hydrogenated benzoxazoles
58with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
CPC
C07D 213/74
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
213Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02having three double bonds between ring members or between ring members and non-ring members
04having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
60with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
72Nitrogen atoms
74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
C07D 263/58
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
263Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
52condensed with carbocyclic rings or ring systems
54Benzoxazoles; Hydrogenated benzoxazoles
58with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Applicants
  • SMITHKLINE BEECHAM PLC [GB/GB]; New Horizons Court Brentford Middlesex TW8 9EP, GB (MG)
  • HAIGH, David [GB/GB]; GB (UsOnly)
  • RAMI, Harshad, Kantilal [GB/GB]; GB (UsOnly)
Inventors
  • HAIGH, David; GB
  • RAMI, Harshad, Kantilal; GB
Agents
  • GIDDINGS, Peter, John; SmithKline Beecham Corporate Intellectual Property SB House, Great West Road Brentford Middlesex TW8 9BD, GB
Priority Data
9415330.129.07.1994GB
9425599.919.12.1994GB
9509923.017.05.1995GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) BENZOXAZOLES AND PRYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF THE TYPE II DIABETES
(FR) BENZOXOAZOLES ET DERIVES DE PRYRIDINE DESTINES A ETRE UTILISES POUR LE TRAITEMENT DU DIABETE TARDIF
Abstract
(EN)
A compound of formula (I): or a pharmaceutically acceptable salt thereof, and/or a pharmaceutically acceptable solvate thereof, wherein Ro represents 2-benzoxazolyl or 2-pyridyl and R1 represents CH2OCH3 or CF3; a process for the preparation of such compounds, a pharmaceutical composition containing such compounds and the use of such compounds and compositions in medicine.
(FR)
L'invention concerne un composé de formule (I) ou l'un des ses sels pharmaceutiquement acceptables, et/ou l'un de ses solvates pharmaceutiquement acceptables. Dans la formule, Ro représente 2-benzoxazolyle ou 2-pyridyle et R1 représente CH2OCH3 ou CF3. L'invention concerne en outre un procédé de préparation de tels composés, une composition pharmaceutique contenant de tels composés et l'application de tels composés et de telles compositions en médicine.
Also published as
Latest bibliographic data on file with the International Bureau